Align Technology Market Cap 2006-2018 | ALGN
Align Technology market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Align Technology market cap as of April 19, 2019 is $22.52B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $22.518B | $1.966B |
| Align Technology, Inc. is a global medical device company with industry-leading innovative products such as Invisalign clear aligners, iTero Intraoral scanners, and OrthoCAD digital services that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Becton Dickinson (BDX) | United States | $61.317B | 20.37 |
| McKesson (MCK) | United States | $21.887B | 8.52 |
| AmerisourceBergen (ABC) | United States | $15.293B | 11.09 |
| Laboratory Of America Holdings (LH) | United States | $14.330B | 13.18 |
| Cooper (COO) | United States | $13.885B | 24.22 |
| Cardinal Health (CAH) | United States | $13.709B | 9.24 |
| DENTSPLY SIRONA (XRAY) | United States | $11.127B | 24.74 |
| Henry Schein (HSIC) | United States | $9.192B | 14.86 |
| West Pharmaceutical Services (WST) | United States | $8.223B | 39.69 |
| Merit Medical Systems (MMSI) | United States | $3.170B | 34.12 |
| CONMED (CNMD) | United States | $2.242B | 36.43 |
| Patterson (PDCO) | United States | $2.031B | 16.05 |
| Atrion (ATRI) | United States | $1.612B | 47.31 |
| STAAR Surgical (STAA) | United States | $1.380B | 115.59 |
| Antares Pharma (ATRS) | United States | $0.437B | 0.00 |
| Invacare (IVC) | United States | $0.222B | 0.00 |
| Lifevantage (LFVN) | United States | $0.158B | 21.27 |
| Pro-Dex (PDEX) | United States | $0.063B | 28.64 |
| Endologix (ELGX) | United States | $0.060B | 0.00 |
| Biolase (BIOL) | United States | $0.049B | 0.00 |
